SG Americas Securities
TAK icon

SG Americas Securities’s Takeda Pharmaceutical TAK Stock Holding History

SG Americas Securities’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-249,900
Closed -$45K – 3224
2021
Q1 		$45K Buy
+249,900
New +$4.5M ﹤0.01% 3169

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities's TAK Position: Q1 2026 in Review

SG Americas Securities reduced its Takeda Pharmaceutical (TAK) stake by 49% in Q1 2026, selling an estimated $119K and leaving 7,065 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #2830.

SG Americas Securities first reported a position in TAK in Q1 2019 and has held it in 22 quarters since. The position peaked at $610K in Q1 2021. 359 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • SG Americas Securities held 7,065 shares of Takeda Pharmaceutical worth $131K as of Q1 2026.
  • SG Americas Securities sold 6,791 Takeda Pharmaceutical shares in Q1 2026, an estimated $119K.
  • Takeda Pharmaceutical made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2830 holding.
  • SG Americas Securities first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 22 quarters since.
  • SG Americas Securities's Takeda Pharmaceutical position peaked at $610K in Q1 2021.
  • 359 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.